Cleared Traditional

K123281 - ACCULIF TL-PEEK CAGE

K123281 is an FDA 510(k) clearance for ACCULIF TL-PEEK CAGE, manufactured by Coalign Innovations, Inc.. The device is a Class 2 Orthopedic device with product code MAX cleared through the Traditional 510(k) pathway after a 93-day FDA review.

K123281 · Coalign Innovations, Inc. · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
93d
Days
Class 2
Risk

K123281 is an FDA 510(k) clearance for the ACCULIF TL-PEEK CAGE. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Coalign Innovations, Inc. (Washington, US). The FDA issued a Cleared decision on January 23, 2013 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K123281

510(k) Number K123281 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 2012
Decision Date January 23, 2013
Days to Decision 93 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 122d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MAX Device Classification - Class 2, Special Controls

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 896
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K123281.
TM ARDIS INTERBODY SYSTEM INSERTER
K123602 · Zimmer Trabecular Metal Technology · Mar 2013
LUCENT
K122967 · Spinal Elements, Inc. · Feb 2013
XIPHOS
K123969 · Difusion Technologies · Feb 2013
INNESIS PEEK CAGE
K120464 · Bk Meditech, Co., Ltd. · Jan 2013
CALIBER SPACERS
K123231 · Globus Medical, Inc. · Jan 2013
ACCULIF TL AND PL CAGE
K123752 · Coalign Innovations, Inc. · Jan 2013
K123281 · ACCULIF TL-PEEK CAGE
Download PDF FDA Summary Coalign Innovations, …